Dr. Rosenblatt is a subject matter expert in the chemistry and manufacturing controls (CMC) of biotheraputics with a proven 30+ year track record in biotechnology, pharmaceutical, and contracting industry, including positions at Centocor, Johnson and Johnson, and Charles River Laboratories.

Over his career, Dr. Rosenblatt has developed, transferred and validated purification processes for multiple new molecular entities through all stages of drug development, including licensure by the application of an innovative and comprehensive approach. This includes the licensure of a biological drug with current annual sales exceeding $6 billion. He has performed due diligence on Contract Manufacturing Organizations (CMO) including assessment of technical ability, and QA/regulatory status.